Orchid Pharma rallied 3.92% to Rs 1,037.50 after the company said that it has received an approval from Drugs Controller General of India (DCGI) to manufacture and market its new chemical entity active pharmaceutical ingredient (API), Enmetazobactam.
| Subscribe To Our Free Newsletter |
